<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19430571</article-id>
      <article-id pub-id-type="pmc">2678712</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2009.50.2.307</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary Pulmonary Hypertension as a Manifestation of Adult Multi-System Mitochondrial Disorder</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Finsterer</surname>
            <given-names>Josef</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Hospital Rudolfstiftung, Vienna, Austria.</aff>
      <author-notes>
        <corresp>
Corresponding author: Dr. Josef Finsterer, Hospital Rudolfstiftung, Postfach 20, 1180 Vienna, Austria. Tel: 43-1-71165-92085, Fax: 43-1-4781711, <email>fifigs1@yahoo.de</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>30</day>
        <month>4</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>4</month>
        <year>2009</year>
      </pub-date>
      <volume>50</volume>
      <issue>2</issue>
      <fpage>307</fpage>
      <lpage>308</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>9</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>05</day>
          <month>1</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>1</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright: Yonsei University College of Medicine 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Pulmonary artery hypertension (PAH) is characterized by increased blood pressure in the pulmonary arteries either due to heart or pulmonary disease (secondary PAH) or without any detectable cause (primary PAH).<xref ref-type="bibr" rid="B1">1</xref> In single cases, primary PAH occurred in young patients with a mitochondrial disorder (MID).<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref> So far, primary PAH has not been described in an adult patient with a MID.</p>
    <p>A 70 years-old Caucasian female, height 163 cm, was admitted for paresthesias in both lower legs since three weeks and muscle cramps in the thighs after exercise. Her history revealed primary PAH since age 66 years, treated with continuous remodulin infusions intravenously via a Port-a-Cath system (44 lambda/h), chronic obstructive pulmonary disease (Gold IV), emphysema, tricuspid insufficiency, mitral insufficiency grade,<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B3">3</xref> paroxysmal atrial fibrillation, incomplete right bundle branch block, recurrent episodes of heart failure, cataract surgery bilaterally, hyponatriemia, hypokaliemia, hyperuricemia, hyperlipidemia, chronic venous insufficiency, and peripheral occlusive vascular disease 2a. Her family history was positive for myocardial infarction (uncle, brother), but negative for MID.</p>
    <p>Clinical neurologic investigation revealed weakness for head anteflexion (M5-), sicca-syndrome, diffuse weakness of the upper limbs with right-sided and distal predominance (M4 to M5-), diffuse weakness of the lower limbs with distal predominance (M4+ to M5-), diffuse wasting, brisk tendon reflexes, left-sided bradydiadochokinesia, drum stick fingers, left-sided lower limb ataxia, and stocking type hypesthesia. Serum creatine-kinase and lactate were normal. The cerebral CT scan showed atrophy and non-specific hypodensities. Nerve conduction studies revealed sensori-motor polyneuropathy and needle-electromyography was myogenic.</p>
    <p>MID was assumed upon the combination of short stature, cataract, sicca syndrome, hypothyroidism, tetraparesis, tetraspasticity, hyponatriemia, hypokaliemia, polyneuropathy, and myopathy. Peripheral artery obstructive disease was excluded as the cause of her complaints since Doppler investigations were not indicative of severe proximal or distal arterial stenosis or occlusion. Cervical or lumbar disc stenosis was excluded as causes of the described clinical features since weakness included also the head ante-flexors.</p>
    <p>Primary PAH has been reported to be associated with mutations in the bone morphogenetic protein type II receptor (BMPR2), actin A receptor type II-like 1 (ACVRL1) or endoglin genes and occasionally in young MIDs.<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref> In a 3 year-old boy, PAH was diagnosed at age 3 years, because of dyspnea, pedal edema, intolerance to oral intake, somnolence and irritability. Additionally, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome due to the m.3243A &gt; G mutation was diagnosed, manifesting as mild language delay, microcephaly, lactacidosis, myopathy (delayed walking, hypotonia, ragged-red muscle fibers, increased succinate dehydrogenase (SDH) staining in blood vessel walls), epilepsy, and stroke-like episodes.<xref ref-type="bibr" rid="B1">1</xref> PAH was also diagnosed in a newborn and a 7 months-old boy with severe hepatopathy from MID, based on biochemical studies,<xref ref-type="bibr" rid="B2">2</xref> in a 6 weeks-old child with myopathy and cardiomyopathy due to the m.14709T &gt; C mutation,<xref ref-type="bibr" rid="B3">3</xref> in two 6 and 4 months-old girls with stroke-like episodes and epilepsy,<xref ref-type="bibr" rid="B4">4</xref> and in a newborn with COX-deficiency.<xref ref-type="bibr" rid="B5">5</xref> A causal relation between PAH and MID could be explained by widespread membrane depolarization, calcium influx, cellular proliferation, vasoconstriction from mitochondrial dysfunction and decreased production of reactive oxygen species.<xref ref-type="bibr" rid="B6">6</xref></p>
    <p>The present case shows that PAH may occur also in adults together with a MID. Whether there is a causal relation between PAH and MID remains to be elucidated.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sproule</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Dyme</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coku</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de Vinck</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rosenzweig</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>WK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A&gt;G)</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2008</year>
          <comment>(in press)</comment>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barclay</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Sholler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Christodolou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arbuckle</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dorney</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pulmonary hypertension -- a new manifestation of mitochondrial disease</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2005</year>
          <volume>28</volume>
          <fpage>1081</fpage>
          <lpage>1089</lpage>
          <pub-id pub-id-type="pmid">16435201</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Hove</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Freehauf</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vladutiu</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Pancrudo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bonilla</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene</article-title>
          <source>Eur J Pediatr</source>
          <year>2008</year>
          <volume>167</volume>
          <fpage>771</fpage>
          <lpage>776</lpage>
          <pub-id pub-id-type="pmid">17891417</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fasnacht</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huisman</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Neuhaus</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Boltshauser</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Siblings with infantile cerebral stroke and delayed multivessel involvement -- a new hereditary vasculopathy?</article-title>
          <source>Eur J Paediatr Neurol</source>
          <year>2007</year>
          <volume>11</volume>
          <fpage>292</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">17428710</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venditti</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Huff</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peterside</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Munson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>HS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital cardiomyopathy and pulmonary hypertension: another fatal variant of cytochrome-c oxidase deficiency</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>735</fpage>
          <lpage>739</lpage>
          <pub-id pub-id-type="pmid">15505378</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waypa</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Schumacker</surname>
              <given-names>PT</given-names>
            </name>
          </person-group>
          <article-title>Role for mitochondrial reactive oxygen species in hypoxic pulmonary vasoconstriction</article-title>
          <source>Novartis Found Symp</source>
          <year>2006</year>
          <volume>272</volume>
          <fpage>176</fpage>
          <lpage>192</lpage>
          <comment>discussion 192-5, 214-7</comment>
          <pub-id pub-id-type="pmid">16686436</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
